346 related articles for article (PubMed ID: 30607001)
1. Molecular signatures of multiple myeloma progression through single cell RNA-Seq.
Jang JS; Li Y; Mitra AK; Bi L; Abyzov A; van Wijnen AJ; Baughn LB; Van Ness B; Rajkumar V; Kumar S; Jen J
Blood Cancer J; 2019 Jan; 9(1):2. PubMed ID: 30607001
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiles of tumor biology provide a novel approach to prognosis and may guide the selection of therapeutic targets in multiple myeloma.
Anguiano A; Tuchman SA; Acharya C; Salter K; Gasparetto C; Zhan F; Dhodapkar M; Nevins J; Barlogie B; Shaughnessy JD; Potti A
J Clin Oncol; 2009 Sep; 27(25):4197-203. PubMed ID: 19636021
[TBL] [Abstract][Full Text] [Related]
3. The Pattern of Mesenchymal Stem Cell Expression Is an Independent Marker of Outcome in Multiple Myeloma.
Schinke C; Qu P; Mehdi SJ; Hoering A; Epstein J; Johnson SK; van Rhee F; Zangari M; Thanendrarajan S; Barlogie B; Davies FE; Yaccoby S; Morgan GJ
Clin Cancer Res; 2018 Jun; 24(12):2913-2919. PubMed ID: 29563136
[No Abstract] [Full Text] [Related]
4. The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: Ready for prime time?
Höllein A; Twardziok SO; Walter W; Hutter S; Baer C; Hernandez-Sanchez JM; Meggendorfer M; Haferlach T; Kern W; Haferlach C
Cancer Genet; 2020 Apr; 242():15-24. PubMed ID: 31980417
[TBL] [Abstract][Full Text] [Related]
5. Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.
Laganà A; Perumal D; Melnekoff D; Readhead B; Kidd BA; Leshchenko V; Kuo PY; Keats J; DeRome M; Yesil J; Auclair D; Lonial S; Chari A; Cho HJ; Barlogie B; Jagannath S; Dudley JT; Parekh S
Leukemia; 2018 Jan; 32(1):120-130. PubMed ID: 28642592
[TBL] [Abstract][Full Text] [Related]
6. Comparative Analysis of Droplet-Based Ultra-High-Throughput Single-Cell RNA-Seq Systems.
Zhang X; Li T; Liu F; Chen Y; Yao J; Li Z; Huang Y; Wang J
Mol Cell; 2019 Jan; 73(1):130-142.e5. PubMed ID: 30472192
[TBL] [Abstract][Full Text] [Related]
7. MYC protein expression is detected in plasma cell myeloma but not in monoclonal gammopathy of undetermined significance (MGUS).
Xiao R; Cerny J; Devitt K; Dresser K; Nath R; Ramanathan M; Rodig SJ; Chen BJ; Woda BA; Yu H
Am J Surg Pathol; 2014 Jun; 38(6):776-83. PubMed ID: 24705315
[TBL] [Abstract][Full Text] [Related]
8. SPARTA: Simple Program for Automated reference-based bacterial RNA-seq Transcriptome Analysis.
Johnson BK; Scholz MB; Teal TK; Abramovitch RB
BMC Bioinformatics; 2016 Feb; 17():66. PubMed ID: 26847232
[TBL] [Abstract][Full Text] [Related]
9. Investigation of Gene Expressions of Myeloma Cells in the Bone Marrow of Multiple Myeloma Patients by Transcriptome Analysis.
Sarıman M; Abacı N; Sırma Ekmekçi S; Çakiris A; Perçin Paçal F; Üstek D; Ayer M; Yenerel MN; Beşışık S; Çefle K; Palandüz Ş; Öztürk Ş
Balkan Med J; 2019 Jan; 36(1):23-31. PubMed ID: 30079703
[TBL] [Abstract][Full Text] [Related]
10. Data Analysis in Single-Cell Transcriptome Sequencing.
Gao S
Methods Mol Biol; 2018; 1754():311-326. PubMed ID: 29536451
[TBL] [Abstract][Full Text] [Related]
11. A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival.
Botta C; Di Martino MT; Ciliberto D; Cucè M; Correale P; Rossi M; Tagliaferri P; Tassone P
Blood Cancer J; 2016 Dec; 6(12):e511. PubMed ID: 27983725
[TBL] [Abstract][Full Text] [Related]
12. Rare Cell Type Detection.
Jiang L
Methods Mol Biol; 2019; 1935():79-89. PubMed ID: 30758820
[TBL] [Abstract][Full Text] [Related]
13. A Guide for Designing and Analyzing RNA-Seq Data.
Chatterjee A; Ahn A; Rodger EJ; Stockwell PA; Eccles MR
Methods Mol Biol; 2018; 1783():35-80. PubMed ID: 29767357
[TBL] [Abstract][Full Text] [Related]
14. Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq.
Gerber T; Willscher E; Loeffler-Wirth H; Hopp L; Schadendorf D; Schartl M; Anderegg U; Camp G; Treutlein B; Binder H; Kunz M
Oncotarget; 2017 Jan; 8(1):846-862. PubMed ID: 27903987
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics Pipeline for Transcriptome Sequencing Analysis.
Djebali S; Wucher V; Foissac S; Hitte C; Corre E; Derrien T
Methods Mol Biol; 2017; 1468():201-19. PubMed ID: 27662878
[TBL] [Abstract][Full Text] [Related]
16. High Throughput Sequencing-Based Approaches for Gene Expression Analysis.
Reddy RRS; Ramanujam MV
Methods Mol Biol; 2018; 1783():299-323. PubMed ID: 29767369
[TBL] [Abstract][Full Text] [Related]
17. Development of an RNA sequencing-based prognostic gene signature in multiple myeloma.
Zamani-Ahmadmahmudi M; Nassiri SM; Soltaninezhad F
Br J Haematol; 2021 Jan; 192(2):310-321. PubMed ID: 32410217
[TBL] [Abstract][Full Text] [Related]
18. Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma.
Shukla S; Evans JR; Malik R; Feng FY; Dhanasekaran SM; Cao X; Chen G; Beer DG; Jiang H; Chinnaiyan AM
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27707839
[TBL] [Abstract][Full Text] [Related]
19. Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma.
Bolomsky A; Hose D; Schreder M; Seckinger A; Lipp S; Klein B; Heintel D; Ludwig H; Zojer N
J Hematol Oncol; 2015 Feb; 8():10. PubMed ID: 25887188
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel fusion transcripts in multiple myeloma.
Lin M; Lee PL; Chiu L; Chua C; Ban KHK; Lin AHF; Chan ZL; Chung TH; Yan B; Chng WJ
J Clin Pathol; 2018 Aug; 71(8):708-712. PubMed ID: 29453220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
